Skip to main content

Table 1 Correlation between expression cyclin G2 and clinical Features in Gastric cancer

From: Cyclin G2 suppresses Wnt/β-catenin signaling and inhibits gastric cancer cell growth and migration through Dapper1

Clinicopathologic features n cyclin G2 expression x2 P value
Up-regulate or no change Down-regulate
Age(years)
 60 or younger 40 12 28 0.2209 0.6384
 Older than 60 49 17 32
Gender
 Male 67 21 46 0.1900 0.6629
 Female 22 8 14
Tumor size (cm3)
  ≤ 5 8 6 2 7.1991 0.0073
  > 5 81 23 58
Depth of tumor invasion
 T1-T2 23 9 14 0.6912 0.4057
 T3-T4 64 19 45
Histologic type
 Well and moderate 27 13 14 4.2739 0.0387
 Poor and undifferentiated 62 16 46
TNM stage
 I 15 7 8 7.1151 0.0683
 II 26 8 18
 III 38 8 30
 IV 10 6 4
Metastasis status
 No 79 23 56 3.8547 0.0496
 Yes 10 6 4
  1. NOTE. Cyclin G2 expression was up-regulated or unchanged in 29 gastric cancer tissues, down-regulated in 60 gastric cancer samples compared with the paired adjacent normal tissues. Both depth of tumor invasion and TNM stage: according to 2010 TNM classification of malignant tumors by the International Union Against Cancer. The statistical significance of the individuals was determined with x2 test